Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients
2007

Bmi-1 mRNA as a Prognostic Factor in Breast Cancer

Sample size: 111 publication 10 minutes Evidence: moderate

Author Information

Author(s): Silva Javier, García Vanesa, García José M, Peña Cristina, Domínguez Gemma, Díaz Raquel, Lorenzo Yolanda, Hurtado Alicia, Sánchez Antonio, Bonilla Félix

Primary Institution: Hospital Universitario Puerta de Hierro

Hypothesis

Can Bmi-1 mRNA levels in plasma serve as a prognostic marker for advanced breast cancer patients?

Conclusion

Bmi-1 expression levels in plasma may indicate poor prognosis in breast cancer patients.

Supporting Evidence

  • Bmi-1 mRNA was detected in 43.2% of breast cancer samples.
  • Higher Bmi-1 levels correlated with poor clinical outcomes.
  • The presence of Bmi-1 in plasma was associated with advanced disease stages.

Takeaway

This study found that measuring Bmi-1 in the blood of breast cancer patients could help doctors understand how serious the cancer is.

Methodology

Bmi-1 expression levels were quantified in plasma samples from 111 breast cancer patients and 20 healthy controls using real-time quantitative PCR.

Limitations

The study did not find a significant correlation between Bmi-1 presence and disease-free survival or overall survival in all patients.

Participant Demographics

111 breast cancer patients and 20 healthy controls.

Statistical Information

P-Value

0.019

Confidence Interval

95% CI, 87.62% to 99.38%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1760

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication